Breast cancer expression profiling: the impact of microarray testing on clinical decision making

Clinical Decision ◽

Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

10.1158/1538-7445.sabcs14-p6-08-10 ◽

2015 ◽

Cited By ~ 1

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Meta-Analysis of Prospective European Studies Assessing the Impact of Using The 21-Gene Recurrence Score Assay on Clinical Decision Making in Women With Er-Positive, Her2-Negative Early Stage Breast Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)32871-4 ◽

2012 ◽

Vol 23 ◽

pp. ix97 ◽

Cited By ~ 1

Author(s):

J. Albanell ◽

S. Holt ◽

J. Gligorov ◽

W. Eiermann ◽

C. Svedman

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Early Stage ◽

Meta Analysis ◽

Recurrence Score ◽

Clinical Decision ◽

Early Stage Breast Cancer ◽

Er Positive ◽

Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates?

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.543 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 543-543

Author(s):

Roman Rouzier ◽

David Gentien ◽

Jean Marc Guinebretiere ◽

Marie-Ange Mouret-Reynier ◽

Coraline Dubot ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Multicenter Study ◽

Early Stage ◽

Clinical Decision ◽

Early Stage Breast Cancer ◽

Prospective Multicenter Study ◽

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-013-2603-1 ◽

2013 ◽

Vol 140 (1) ◽

pp. 83-92 ◽

Cited By ~ 27

Author(s):

Salomon M. Stemmer ◽

Shmuel H. Klang ◽

Noa Ben-Baruch ◽

David B. Geffen ◽

Mariana Steiner ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Recurrence Score ◽

Clinical Decision ◽

Breast Cancer Patients ◽

The Impact ◽

Positive Breast Cancer

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1037730 ◽

2015 ◽

Vol 31 (6) ◽

pp. 1129-1137 ◽

Cited By ~ 21

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba-Rodriguez ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Early Stage ◽

Growth Factor Receptor ◽

Clinical Decision ◽

Node Negative ◽

Epidermal Growth ◽

P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer

The Breast ◽

10.1016/s0960-9776(11)70139-4 ◽

2011 ◽

Vol 20 ◽

pp. S43 ◽

Cited By ~ 3

Author(s):

J. Albanell ◽

R. Colomer ◽

M. Ruiz-Borrego ◽

E. Alba ◽

J.A. García Saenz ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Recurrence Score ◽

Clinical Decision ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Annals of Oncology ◽

10.1093/annonc/mdr278 ◽

2012 ◽

Vol 23 (3) ◽

pp. 625-631 ◽

Cited By ~ 82

Author(s):

J. Albanell ◽

A. González ◽

M. Ruiz-Borrego ◽

E. Alba ◽

J.A. García-Saenz ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Recurrence Score ◽

Clinical Decision ◽

Clinicopathological Factors ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

Journal of Personalized Medicine ◽

10.3390/jpm2030071 ◽

2012 ◽

Vol 2 (3) ◽

pp. 71-76

Author(s):

Steven R. Schuster ◽

Barbara A. Pockaj ◽

Mary R. Bothe ◽

Paru S. David ◽

Donald W. Northfelt

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Decision Making ◽

Expression Profiling ◽

Clinical Utility ◽

Early Stage ◽

Clinical Decision ◽

Node Negative ◽

Node Negative Breast Cancer

Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results

Annals of Surgical Treatment and Research ◽

10.4174/astr.2017.92.5.331 ◽

2017 ◽

Vol 92 (5) ◽

pp. 331 ◽

Cited By ~ 5

Author(s):

Hyung Seok Park ◽

Seo-Jin Park ◽

Jee Ye Kim ◽

Sanghwa Kim ◽

Jaegyu Ryu ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Next Generation Sequencing ◽

Cancer Patients ◽

Clinical Decision ◽

High Accuracy ◽

Breast Cancer Patients ◽

Generation Sequencing ◽

Genetic Results

Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer

British Journal of Cancer ◽

10.1038/bjc.2014.120 ◽

2014 ◽

Vol 110 (7) ◽

pp. 1688-1697 ◽

Cited By ~ 53

Author(s):

E A Rakha ◽

D Soria ◽

A R Green ◽

C Lemetre ◽

D G Powe ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Prognostic Index ◽

Clinical Decision ◽

Nottingham Prognostic Index ◽

Decision Making Tool